StreetAlpha.app
Home › Stocks › RMD

Resmed Inc (RMD)

Healthcare
$237.95
▼ −0.12%
LAST CLOSE · NOV 17

ResMed makes CPAP systems, masks, diagnostic services and care software for sleep, breathing and home healthcare. It last closed at $237.95 on Nov 17, down 0.12% on the day. RMD reports earnings on Thu, Jan 28, 2027. The average 12-month price target from 4 analysts is $262.75 (+10.4% from the last close), with a high of $288.00 and a low of $236.00. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in RMD, 0% of them bullish and 100% bearish. In the past 30 days there were 8 dark pool prints totaling $7.4M, the largest $2.2M.

AI Auto Pilots
Is RMD in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$5.7B
+9.0% vs a year ago
Net income
$1.6B
+10.8% vs a year ago
EPS (diluted)
$10.98
+12.4% vs a year ago
Free cash flow
$1.6B
28.1% margin
Valuation
Market cap
$33.5B
140.7M shares
P/E
21.7
Price over 12 month EPS
Price to sales
5.8
Market cap over revenue
Dividend yield
1.03%
$2.46 a share over 12 months
Balance sheet
Cash & equivalents
$1.0B
At Sep 30
Debt
$249.6M
At Sep 30
Shareholder equity
$5.9B
Buybacks
$1.5B
Last 12 months
CEOMichael Farrell
Fiscal year endsJune
ExchangeNYSE
Financials history
FY2022: $3.6B$3.6BFY2022FY2023: $4.2B$4.2BFY2023FY2024: $4.7B$4.7BFY2024FY2025: $5.1B$5.1BFY2025FY2026: $5.7B$5.7BFY2026

From RMD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 30). Last 12 months adds up the four latest quarters.

Next report
Jan 28
2027 · Time not announced
Consensus EPS forecast
$3.03
$1.46B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
4firms
2 Buy2 Hold0 Sell
Each firm's latest rating on RMD in the past 90 days
Average 12-month target
$262.75
▲ 10.4% upside

Based on 4 analysts who set a price target on RMD in the past 90 days. The average target is $262.75, with a high of $288.00 and a low of $236.00, compared with the last close of $237.95.

Low $236.00Avg $262.75High $288.00
Blue marker: last close $237.95
Highest target$288.00
Average target$262.75
Lowest target$236.00
Latest rating changes
RBC CapitalTarget raised
Oct 30Buy$262 → $288
Wells FargoTarget raised
Oct 30Hold$215 → $250
KeybancTarget raised
Oct 30Buy$267 → $277
NeedhamDowngrade
Sep 25Hold$236
RBC CapitalUpgrade
Sep 15Buy$244 → $262
DateFirmActionRatingPrice target
Oct 30RBC CapitalTarget raisedBuy$262 → $288
Oct 30Wells FargoTarget raisedHold$215 → $250
Oct 30KeybancTarget raisedBuy$267 → $277
Sep 25NeedhamDowngradeHold$236
Sep 15RBC CapitalUpgradeBuy$244 → $262
Loading…

Technical Analysis

RMD · as of the Nov 17 close · updated after every close
Moving sideways

The stock sits between its 20 and 50 day averages. It is 6% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 51). The nearest support is the Pivot S1 at $235.91, and the nearest resistance the Pivot at $238.54.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 2.9%/day
Key levels
$277.6752 week high+16.7%
$242.40Swing high (Sep 1)+1.9%
$241.3620 day average+1.4%
$240.57Pivot R1+1.1%
$238.54Pivot+0.2%
$237.95Last close
$235.91Pivot S1−0.9%
$232.6950 day average−2.2%
$230.00Swing low (Nov 11)−3.3%
$224.19100 day average−5.8%
$223.69200 day average−6.0%
$180.2752 week low−24.2%
Indicators
RSI (14)50.64Middle of its rangeNeutral
MACD0.73Below its signal lineBearish
Stochastic52.0Middle of its rangeNeutral
ADX (14)23.1Weak trend
Williams %R-49.9Oversold below −80, overbought above −20Neutral
CCI (20)-26.5Oversold below −100, overbought above 100Neutral
Rate of change+4.8%Change over 10 sessionsBullish
ATR (14)$6.92Typical daily range, 2.9% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for RMD

What happened before

See how RMD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow RMD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How RMD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Aug 27 – Aug 27
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
8
Notional
$7.4M
Largest print
$2.2M
Loading…

RMD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼385 buying vs 456 selling
  • ▼Held by funds -5.7 pts
  • ▼Funds holding -11
  • ●Superinvestors: 2 added, 2 cut
  • ▲Put/call 3.26 to 1.55
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding880891−1.2%
In funds' top 1034−25.0%
Held by funds65.8%71.5%−5.7 pts
New / increased105 / 28083 / 310−2.0%
Reduced / sold out348 / 108358 / 138−8.1%
Put/call ratio1.553.26−52.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See RMD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

RMD Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$1.5B
4.4% yield
Left in program
4.3M sh
3.0% of shares
Shares outstanding, 12 months
−3.6%
Fewer shares
Last quarter
$846.3M
Sep 2026
Avg price paid, last quarter
$232.29
3.6M shares bought
S&P 500 rank by spending
#137 of 358
 
Spent each quarter, last 3 yearsTop bar $846.3M
Dec 2023: $50.0M, average price $149.04Mar 2024: $50.0M, average price $191.76Jun 2024: $50.0M, average price $215.85Sep 2024: $50.0M, average price $225.23Dec 2024: $75.0M, average price $244.42Mar 2025: $75.0M, average price $238.78Jun 2025: $100.0M, average price $238.81Sep 2025: $149.9M, average price $286.42Dec 2025: $175.1M, average price $248.86Mar 2026: $175.0M, average price $259.87Jun 2026: $200.0M, average price $205.75Sep 2026: $846.3M, average price $232.29
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RMD is in one of them and how their past RMD trades turned out.

RMD in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered RMD in an article yet. Here's the latest on the wider market.

RMD Congress Trades

All congress trades →
Trades, 12 months
18
Buys
10
56%
Sells
8
44%
People
3
Last filed Oct 7
Who traded RMD · since 2017
Latest 5 filings of 62
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$15K – $50KTraded Aug 26, 2026Filed Sep 22, 2026
$1K – $15KTraded Jul 8, 2026Filed Sep 22, 2026
$1K – $15KTraded Aug 3, 2026Filed Sep 4, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Donald J TrumpExecutive branchSell$15K – $50KAug 26, 2026Sep 22, 202627 d
Donald J TrumpExecutive branchSell$1K – $15KJul 8, 2026Sep 22, 202676 d
Ro KhannaD · CABuy$1K – $15KAug 3, 2026Sep 4, 202632 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Resmed

ResMed is a medical device and software company based in San Diego, California. Its main products are CPAP systems and masks that treat sleep apnea and other breathing disorders, along with diagnostic testing services and connected tools that help clinicians and patients manage therapy. The company also sells software to residential care providers and home medical equipment suppliers. Its customers include patients, physicians, and care providers in many countries.

Headquarters
San Diego, CA
Founded
1989